|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2000-11-20
|
|
pubmed:abstractText |
131I therapy is a widely accepted treatment for metastatic differentiated thyroid cancer. To investigate the feasibility of 131I therapy for breast cancer, we established breast cancer cells stably expressing Na-/I- symporter (NIS) gene that can be modulated and studied in vitro and in vivo.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0161-5505
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
41
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1898-904
|
|
pubmed:dateRevised |
2003-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:11079502-Animals,
pubmed-meshheading:11079502-Carrier Proteins,
pubmed-meshheading:11079502-Gene Therapy,
pubmed-meshheading:11079502-Iodides,
pubmed-meshheading:11079502-Iodine Radioisotopes,
pubmed-meshheading:11079502-Mammary Neoplasms, Experimental,
pubmed-meshheading:11079502-Membrane Proteins,
pubmed-meshheading:11079502-Mice,
pubmed-meshheading:11079502-Mice, Nude,
pubmed-meshheading:11079502-Neoplasm Transplantation,
pubmed-meshheading:11079502-Symporters,
pubmed-meshheading:11079502-Transfection,
pubmed-meshheading:11079502-Tumor Cells, Cultured
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Establishment and characterization of a breast cancer cell line expressing Na+/I- symporters for radioiodide concentrator gene therapy.
|
|
pubmed:affiliation |
Department of Nuclear Medicine and Diagnostic Imaging, Graduate School of Medicine, Kyoto University, Japan.
|
|
pubmed:publicationType |
Journal Article
|
